1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Prodromal Symptoms: new trials by email Literature Review of Prodromal Symptoms trials Research Report on Prodromal Symptoms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi VX15/2503, Placebo - Huntington's Disease | Phase 2 | Completed | Vaccinex Inc. | 301 | 2015-07-01 | 2022-05-02 |
Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Chorea (1) · Cognition Disorders (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dementia (1) · Dyskinesias (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Mental Disorders (1) · Movement Disorders (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1)
pepinemab (1)
Vaccinex Inc. (1)
Canada (1) · United States (1)